BIOGEN INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 222.8 USD | +1.38% |
|
+4.33% | -13.92% |
| 09/05 | MOVES -Lazard hires veteran healthcare dealmaker Colocci as vice chairman | RE |
| 08/05 | Redburn Atlantic Adjusts Price Target on Biogen to $235 From $275, Keeps Neutral Rating | MT |
ETFs positioned on Biogen Inc.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.21% | 0 M€ | +1.36% | - | |
| 0.21% | 0 M€ | +5.47% | - | |
| 0.20% | 219 M€ | +17.17% | - | |
| 0.20% | 1,448 M€ | -.--% | - | |
| 0.20% | 0 M€ | +9.11% | ||
| 0.20% | 330 M€ | -.--% | - | |
| 0.20% | 2 M€ | +14.69% | - | |
| 0.18% | 0 M€ | +18.09% | - | |
| 0.18% | 0 M€ | +4.60% | - | |
| 0.18% | 0 M€ | +8.05% | ||
| 0.18% | 276 M€ | +11.40% | - | |
| 0.18% | 1,174 M€ | +23.54% | ||
| 0.18% | 655 M€ | -.--% | - | |
| 0.18% | 273 M€ | -.--% | ||
| 0.17% | 36 M€ | +22.19% | ||
| 0.17% | 0 M€ | +7.06% | ||
| 0.16% | 0 M€ | +18.44% | - | |
| 0.15% | 0 M€ | +12.65% | ||
| 0.14% | 1,848 M€ | +18.39% | - | |
| 0.14% | 559 M€ | +14.30% | - | |
| 0.13% | 1 M€ | +0.04% | ||
| 0.12% | 6 M€ | +17.98% | - | |
| 0.12% | 0 M€ | +6.76% | - | |
| 0.12% | 0 M€ | +3.56% | - | |
| 0.12% | 0 M€ | +3.88% | - | |
| 0.12% | 205 M€ | -.--% | ||
| 0.11% | 0 M€ | +19.79% | - | |
| 0.10% | 0 M€ | -.--% | - | |
| 0.10% | 0 M€ | +8.31% | - | |
| 0.10% | 0 M€ | +11.06% |
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
Pharmaceuticals
Calendar
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
BUY
Number of Analysts
34
Last Close Price
219.7
USD
Average target price
285.9
USD
Spread / Average Target
+30.13%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -13.92% | 31.99B | |
| -2.76% | 88.91B | |
| +2.76% | 41.25B | |
| +50.51% | 24.73B | |
| -15.25% | 15.54B | |
| -39.93% | 12.07B | |
| -9.08% | 12.05B | |
| -14.80% | 12.02B | |
| +6.22% | 8.84B | |
| -4.68% | 8.3B |
- Stock Market
- Equities
- BIIB Stock
- Funds and ETFs Biogen Inc.